Cybin Inc. Common Stock
HELP
Classement en actions
#11557
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Prix de l'action
$10.30
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$638.32M
Changement (1 jour)
2.88%
Changement (1 an)
9,119.52%
Pays
CA
Échange Cybin Inc. Common Stock (HELP)
Catégorie
Healthcare
Historique du prix de l'action pour Cybin Inc. Common Stock (HELP)
Prix de clôture le plus élevé : $0.12 le 2023-10-01
Prix de clôture le plus bas : $0.40 le 2021-06-01
Prix de clôture le plus bas : $0.40 le 2021-06-01
Historique du prix de l'action de Cybin Inc. Common Stock de 2021 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.31 | 8.49% |
CH
|
